-
1
-
-
57349151521
-
Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity
-
Dellas C, Schäfer K, Rohm I, et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008; 100: 1123-1129.
-
(2008)
Thromb Haemost
, vol.100
, pp. 1123-1129
-
-
Dellas, C.1
Schäfer, K.2
Rohm, I.3
-
2
-
-
34247467536
-
Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients
-
Corica F, Corsonello A, Lucchetti M, et al. Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients. Int J Obes (Lond) 2007; 31: 842-849.
-
(2007)
Int J Obes (Lond)
, vol.31
, pp. 842-849
-
-
Corica, F.1
Corsonello, A.2
Lucchetti, M.3
-
3
-
-
26244437056
-
Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation
-
Canavan B, Salem RO, Schurgin S, et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab 2005; 90: 5779-5785.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5779-5785
-
-
Canavan, B.1
Salem, R.O.2
Schurgin, S.3
-
4
-
-
45849092207
-
Potentiation and priming of platelet activation: A potential target for antiplatelet therapy
-
Gresele P, Falcinelli E, Momi S. Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. Trends Pharmacol Sci 2008; 29: 352-360.
-
(2008)
Trends Pharmacol Sci
, vol.29
, pp. 352-360
-
-
Gresele, P.1
Falcinelli, E.2
Momi, S.3
-
5
-
-
33750043782
-
Development of leptin anatagonists and their potential use in experimental biology and medicine
-
Gertler A. Development of leptin anatagonists and their potential use in experimental biology and medicine. Trends Endocrinol. Metab 2006; 17: 372-378.
-
(2006)
Trends Endocrinol. Metab
, vol.17
, pp. 372-378
-
-
Gertler, A.1
-
6
-
-
0035909997
-
Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
-
Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-3056.
-
(2001)
Circulation
, vol.104
, pp. 3052-3056
-
-
Wallace, A.M.1
McMahon, A.D.2
Packard, C.J.3
-
7
-
-
7044222808
-
Plasma leptin and prognosis in patients with established coronary atherosclerosis
-
Wolk R, Berger P, Lennon RJ, et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44: 1819-1824.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1819-1824
-
-
Wolk, R.1
Berger, P.2
Lennon, R.J.3
-
8
-
-
0037012483
-
Effect of leptin on arterial thrombosis following vascular injury in mice
-
Bodary PF, Westrick RJ, Wickenheiser KJ, et al. Effect of leptin on arterial thrombosis following vascular injury in mice. J Am Med Assoc 2002; 287: 1706-1709.
-
(2002)
J Am Med Assoc
, vol.287
, pp. 1706-1709
-
-
Bodary, P.F.1
Westrick, R.J.2
Wickenheiser, K.J.3
|